GlassScriptPhysician profile
Tara Gunter
NPI 1093033060
$1,315.15
in general payments reported to CMS, 2019-2025
20 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $290 · 2022: $282 · 2023: $343 · 2024: $269 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $189.39 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $186.08 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $161.24 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $146.00 | 2021-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $110.72 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.24 | 2021-2023 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $69.08 | 2022-2024 | Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $48.29 | 2022-2023 | Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $45.06 | 2022 | |
| Merck Sharp & Dohme LLC | $43.45 | 2022-2023 | Verquvo, Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $33.78 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.17 | 2021-2023 | Jardiance |
| Irhythm Technologies, INC. | $28.67 | 2021 | |
| Amgen INC. | $25.97 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $24.21 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $22.56 | 2021 | |
| Exact Sciences Corporation | $19.21 | 2023 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $14.71 | 2021 | |
| Currax Pharmaceuticals LLC | $14.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.08 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Gunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.